BACKGROUND: Malaysia has been experiencing significant drug abuse problems since the 1970s, and drug abuse is the major driver of HIV transmission in Malaysia. We investigated risk factors for HIV associated with use of amphetamine type stimulants (ATS) among not-in-treatment opiate injectors in Malaysia. METHODS: Between October of 2006 and May of 2008, we conducted a series of surveys in three major urban areas of Malaysia. A total of 732 opiate IDUs (679 males and 53 females) were enrolled in the three surveys. The survey instruments consisted of a structured interview on demographic characteristics, drug use history (including year of first use, and past month history of use of illicit drugs; lifetime and past month history of IDU or needle or equipment sharing), and HIV status. RESULTS: There were 194/704 (27.6%) HIV positive participants in the sample. Two factors were significantly associated with HIV infection in this sample: lifetime history of ATS use (OR [95%CI]: 2.3 [1.5-3.6]) and lifetime history of sharing of injection equipment (OR [95% CI]: 4.2 [1.8-9.8]). Both HIV-positive and HIV-negative participants reported high levels of current needle/equipment sharing practices: 82% vs. 75%, respectively. CONCLUSIONS: ATS use spread rapidly in the study sample after 1997 and is associated with an increased risk of HIV infection in this population already at high risk because of opiate IDU. Out-of-treatment IDUs in Malaysia engage in high risk behaviors regardless of their HIV status. Increased education and public health prevention measures are needed to reduce HIV transmission risks in this population.
BACKGROUND: Malaysia has been experiencing significant drug abuse problems since the 1970s, and drug abuse is the major driver of HIV transmission in Malaysia. We investigated risk factors for HIV associated with use of amphetamine type stimulants (ATS) among not-in-treatment opiate injectors in Malaysia. METHODS: Between October of 2006 and May of 2008, we conducted a series of surveys in three major urban areas of Malaysia. A total of 732 opiate IDUs (679 males and 53 females) were enrolled in the three surveys. The survey instruments consisted of a structured interview on demographic characteristics, drug use history (including year of first use, and past month history of use of illicit drugs; lifetime and past month history of IDU or needle or equipment sharing), and HIV status. RESULTS: There were 194/704 (27.6%) HIV positive participants in the sample. Two factors were significantly associated with HIV infection in this sample: lifetime history of ATS use (OR [95%CI]: 2.3 [1.5-3.6]) and lifetime history of sharing of injection equipment (OR [95% CI]: 4.2 [1.8-9.8]). Both HIV-positive and HIV-negative participants reported high levels of current needle/equipment sharing practices: 82% vs. 75%, respectively. CONCLUSIONS:ATS use spread rapidly in the study sample after 1997 and is associated with an increased risk of HIV infection in this population already at high risk because of opiate IDU. Out-of-treatment IDUs in Malaysia engage in high risk behaviors regardless of their HIV status. Increased education and public health prevention measures are needed to reduce HIV transmission risks in this population.
Authors: Michael W Plankey; David G Ostrow; Ron Stall; Christopher Cox; Xiuhong Li; James A Peck; Lisa P Jacobson Journal: J Acquir Immune Defic Syndr Date: 2007-05-01 Impact factor: 3.731
Authors: Louisa Degenhardt; Bradley Mathers; Mauro Guarinieri; Samiran Panda; Benjamin Phillips; Steffanie A Strathdee; Mark Tyndall; Lucas Wiessing; Alex Wodak; John Howard Journal: Int J Drug Policy Date: 2010-02-01
Authors: Catherine G Sutcliffe; Apinun Aramrattana; Susan G Sherman; Bangorn Sirirojn; Danielle German; Kanlaya Wongworapat; Vu Minh Quan; Rassamee Keawvichit; David D Celentano Journal: Sex Transm Dis Date: 2009-05 Impact factor: 2.830
Authors: Rebecca McKetin; Nicholas Kozel; Jeremy Douglas; Robert Ali; Balasingam Vicknasingam; Johannes Lund; Jih-Heng Li Journal: Drug Alcohol Rev Date: 2008-05
Authors: Michael Martin; Suphak Vanichseni; Pravan Suntharasamai; Philip A Mock; Frits van Griensven; Punnee Pitisuttithum; Jordan W Tappero; Sithisat Chiamwongpaet; Udomsak Sangkum; Dwip Kitayaporn; Marc Gurwith; Kachit Choopanya Journal: Int J Drug Policy Date: 2010-01-15
Authors: Farrah Khan; Archana Krishnan; Mansur A Ghani; Jeffrey A Wickersham; Jeannia J Fu; Sin How Lim; Sangeeth Kaur Dhaliwal; Adeeba Kamarulzaman; Frederick L Altice Journal: Subst Use Misuse Date: 2017-02-22 Impact factor: 2.164
Authors: Weng-Tink Chooi; Norzarina Mohd Zaharim; Alethea Desrosiers; Imran Ahmad; Mohd Azhar Mohd Yasin; Sharifah Z Syed Jaapar; Richard S Schottenfeld; Balasingam K Vicknasingam; Marek C Chawarski Journal: J Psychoactive Drugs Date: 2017-06-29
Authors: Richard S Schottenfeld; Marek C Chawarski; Mehmet Sofuoglu; Weng-Tink Chooi; Norzarina M Zaharim; M Azhar M Yasin; Imran Ahmad; Sharifah Zubaidiah Syed Jaapar; B Kasinather Vicknasingam Journal: Drug Alcohol Depend Date: 2018-03-10 Impact factor: 4.492
Authors: Shruti H Mehta; Aylur K Srikrishnan; Eva Noble; Canjeevaram K Vasudevan; Suniti Solomon; M Suresh Kumar; Sunil S Solomon Journal: Drug Alcohol Depend Date: 2013-12-17 Impact factor: 4.492
Authors: Balasingam Vicknasingam; N A Mohd Salleh; Ravi Ramadah; Darshan Singh; Adeeba Kamarulzaman; Marek C Chawarski Journal: Int J Drug Policy Date: 2021-06-07
Authors: Edouard Coupet; Gail D'Onofrio; Marek Chawarski; E J Edelman; Patrick G O'Connor; Patricia Owens; Shara Martel; David A Fiellin; Ethan Cowan; Lynne Richardson; Kristen Huntley; Lauren K Whiteside; Michael S Lyons; Richard E Rothman; Michael Pantalon; Kathryn Hawk Journal: Drug Alcohol Depend Date: 2020-11-26 Impact factor: 4.492